Cetirizine hydrochloride is generally considered low-risk during pregnancy, though it’s not the first-choice antihistamine most guidelines recommend. It carries an FDA Pregnancy Category B rating, meaning animal studies showed no harm to developing offspring, and the limited human data available also show no increased risk of birth defects. That said, the picture is more nuanced than a simple “safe” or “not safe.”
What Pregnancy Category B Means
The FDA assigned cetirizine a Category B classification based on animal testing in mice, rats, and rabbits at doses ranging from 40 to 220 times the maximum recommended human dose. None of these studies found evidence of birth defects. Category B is the second-safest tier in the old FDA ranking system (Category A being the safest), and it means the drug has not shown risk in animal reproduction studies but lacks well-controlled studies in pregnant women.
The absence of large, rigorous human trials is common for medications in pregnancy, since researchers can’t ethically randomize pregnant women to take drugs for study purposes. Instead, the safety picture comes from observational data collected after women used the medication during real pregnancies.
What the Human Studies Show
Two cohort studies have specifically examined cetirizine exposure in the first trimester, the period when organs are forming and the risk of structural birth defects is highest. In one study from the Motherisk Program, none of the 33 women who took cetirizine in the first trimester had a baby with a major birth defect. A larger study using data from the Berlin Teratology Information Service found birth defects in 3 of 177 first-trimester exposures (1.7%), compared to 1.6% in women who took no known harmful medications. That difference was statistically meaningless.
Research on miscarriage and preterm birth is also reassuring. A study evaluating early first-trimester antihistamine use found no association with spontaneous abortion or preterm birth. The adjusted risk was essentially the same for antihistamine users and non-users.
Why It’s Not Always the First Choice
Despite its reassuring safety profile, cetirizine is often listed as a second-line option during pregnancy rather than a first-line one. The reason is straightforward: older antihistamines like chlorpheniramine have been used for decades longer, and the sheer volume of pregnancy exposure data is much larger. More data generally means more confidence.
Both the American College of Obstetricians and Gynecologists (ACOG) and the American College of Allergy, Asthma and Immunology (ACAAI) recommend chlorpheniramine as a first-choice antihistamine for pregnant women. They recommend cetirizine and loratadine after the first trimester for women who can’t tolerate or don’t respond to chlorpheniramine.
That said, these guidelines involve some trade-offs. Older antihistamines like chlorpheniramine cause significantly more drowsiness and have anticholinergic side effects like dry mouth and constipation. The ARIA (Allergic Rhinitis and Its Impact on Asthma) guidelines have actually argued that first-generation antihistamines have an unfavorable risk-benefit ratio even outside of pregnancy because of these side effects. So the “safest” option on paper may not always be the most practical one for daily life, especially if you’re already dealing with pregnancy fatigue.
First Trimester vs. Later Trimesters
The first trimester is the most sensitive window for any medication exposure because that’s when the baby’s major organs and structures develop. Most of the reassuring data on cetirizine comes from first-trimester exposures, which is good news since that’s the period of greatest concern. By the second and third trimesters, the risk of structural birth defects from medication drops considerably, and professional guidelines are more comfortable with cetirizine use during this period.
If you’re already past the first trimester and need allergy relief, cetirizine is one of the better-studied options available.
Effects on Child Development
One concern parents sometimes have is whether antihistamines could affect a child’s brain development, even if they don’t cause visible birth defects. A large study followed about 600 young children, roughly half receiving cetirizine and half receiving a placebo, and tracked their behavioral development, cognitive abilities, and motor milestones from an average of 32 to 53 months of age. There were no significant differences between the two groups on any measure, during treatment or after it ended.
Cetirizine While Breastfeeding
Cetirizine passes into breast milk in small amounts. A breastfed infant receives roughly 1.8% of the mother’s weight-adjusted dose, with a worst-case estimate of about 3.4%. These numbers are well below the threshold that would typically raise concern.
Small, occasional doses are considered acceptable during breastfeeding. Larger or more frequent doses may cause mild drowsiness in some infants. In a follow-up study of mothers using various antihistamines while nursing, about 10% reported irritability or colicky symptoms in their infants, and 1.6% reported drowsiness. None of these reactions were serious enough to need medical attention.
One practical consideration: cetirizine combined with a decongestant like pseudoephedrine (common in combo allergy products) may reduce milk supply, particularly in early breastfeeding before supply is well established. If you’re nursing, plain cetirizine without a decongestant is the better choice.
Practical Takeaways
If you’re pregnant and dealing with allergies, cetirizine is not considered dangerous. The birth defect rate among women who took it in early pregnancy is no different from the general population rate. It holds a Category B rating, and no study has found a meaningful signal of harm.
The main nuance is one of positioning. Guidelines tend to recommend trying an older antihistamine like chlorpheniramine first, with cetirizine as a well-supported backup, particularly after the first trimester. In practice, many women use cetirizine throughout pregnancy without complications, and some providers are comfortable recommending it from the start, especially when older antihistamines cause too much sedation or aren’t effective enough.